Zoetis (ZTS) Stock
NASDAQ · ZTS
71.33
Fundamentals
Market cap
$29.50B
Price / Earnings ratio
11.3x
Price / Sales ratio
3.1x
Price / Book ratio
9.4x
Return on assets
0.2%
Ex-Dividend date
20 Jul 2026
Last payment date
N/A
Dividend amount
$0.53
Dividend yield
2.9%
Debt / Equity ratio
N/A
Latest news
About Zoetis
Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways. Building on 60 years of experience, we deliver quality medicines and vaccines, complemented by diagnostic products and genetic tests and supported by a range of services.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees14,500
CEOMs. Kristin C. Peck
IPO DateFeb 1, 2013
HeadquartersParsippany, NJ
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Kristin C. Peck | CEO & Director | 1971 |
| Mr. Wetteny N. Joseph C.P.A. | Executive VP & CFO | 1972 |
| Ms. Roxanne Lagano | Executive VP, General Counsel & Corporate Secretary | 1965 |
| Dr. Robert J. Polzer Ph.D. | Scientific Advisor | 1969 |
| Mr. Jamie Brannan | Executive VP & Chief Commercial Officer | 1973 |
| Mr. Keith Sarbaugh | Executive VP & Chief Digital and Technology Officer | 1979 |
| Mr. Steven Frank | Vice President of Investor Relations | — |
| Ms. Julie A. Fuller | Executive VP, Chief Human Resources Officer & Global Operations | 1973 |
| Mr. Abhay U. Nayak | Executive VP & President of U.S. Commercial Operations | 1988 |
| Ms. Jeannette Ferran Astorga | Executive VP of Corporate Affairs & Chief Sustainability Officer | 1976 |
Fundamentals
Valuation
Market cap$29.50B
Price-to-sales ratio3.10
Price-to-book value9.37
Price-earnings ratio11.30
Return on Equity62.00%
Return on Sales0.37%
Return on Assets0.18%
PEG ratio6.72
Earnings Per Share
Earnings Per Share$6.08
Income Statement
Average volume4,799,048
EBITDA$4.04B
1 year high (52w)$148.79
1 year low (52w)$71.00
Dividend
Ex dividend date20 Jul 2026
Dividend amount$0.53
Dividend yield2.93%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



